These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 16954456)

  • 1. Cyclooxygenase-2 plays an essential part in cardioprotection of delayed phase of recombinant human erythropoietin preconditioning in rats.
    Liu X; Zhou Z; Feng X; Jia Z; Jin Y; Xu J
    Postgrad Med J; 2006 Sep; 82(971):588-93. PubMed ID: 16954456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cardioprotection of recombinant human erythropoietin pretreatment on ischemia-reperfused hearts and mechanism thereof: experiment with rats].
    Liu XM; Jia Z; Zhou ZQ; Xu JG
    Zhonghua Yi Xue Za Zhi; 2007 Sep; 87(35):2463-7. PubMed ID: 18067805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclooxygenase-1 mediates the final stage of morphine-induced delayed cardioprotection in concert with cyclooxygenase-2.
    Jiang X; Shi E; Nakajima Y; Sato S; Ohno K; Yue H
    J Am Coll Cardiol; 2005 May; 45(10):1707-15. PubMed ID: 15893191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of the cardioprotection of rhEPO pretreatment on suppressing the inflammatory response in ischemia-reperfusion.
    Liu X; Xie W; Liu P; Duan M; Jia Z; Li W; Xu J
    Life Sci; 2006 Apr; 78(19):2255-64. PubMed ID: 16336978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant human erythropoietin (rhEPO) preconditioning on nuclear factor-kappa B (NF-kB) activation & proinflammatory cytokines induced by myocardial ischaemia-reperfusion.
    Liu X; Shen J; Jin Y; Duan M; Xu J
    Indian J Med Res; 2006 Sep; 124(3):343-54. PubMed ID: 17085838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of cyclooxygenase-2 on ischemic preconditioning of skin flaps.
    Dikici MB; Coskunfirat OK; Uslu A
    Ann Plast Surg; 2009 Jul; 63(1):100-4. PubMed ID: 19546683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [COX-2 or nNOS mediates cardioprotection during the final stage of the late phase of ischemic preconditioning].
    Xu Q; Tang B; Zhang N; Song L; Zhang Z; Chen Y
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2008 Dec; 25(6):1411-4. PubMed ID: 19166220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isoflurane produces delayed preconditioning against myocardial ischemia and reperfusion injury: role of cyclooxygenase-2.
    Tanaka K; Ludwig LM; Krolikowski JG; Alcindor D; Pratt PF; Kersten JR; Pagel PS; Warltier DC
    Anesthesiology; 2004 Mar; 100(3):525-31. PubMed ID: 15108964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Xenon induces late cardiac preconditioning in vivo: a role for cyclooxygenase 2?
    Weber NC; Frässdorf J; Ratajczak C; Grueber Y; Schlack W; Hollmann MW; Preckel B
    Anesth Analg; 2008 Dec; 107(6):1807-13. PubMed ID: 19020121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Possible involvement of erythropoietin in remote renal preconditioning-induced cardioprotection in rats.
    Diwan V; Jaggi AS; Singh M; Singh N; Singh D
    J Cardiovasc Pharmacol; 2008 Feb; 51(2):126-30. PubMed ID: 18287879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant human erythropoietin pretreatment attenuates myocardial infarct size: a possible mechanism involves heat shock Protein 70 and attenuation of nuclear factor-kappaB.
    Xu B; Dong GH; Liu H; Wang YQ; Wu HW; Jing H
    Ann Clin Lab Sci; 2005; 35(2):161-8. PubMed ID: 15943180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Roles of cyclooxygenase 2 in sevoflurane- and olprinone-induced early phase of preconditioning and postconditioning against myocardial infarction in rat hearts.
    Tosaka S; Tosaka R; Matsumoto S; Maekawa T; Cho S; Sumikawa K
    J Cardiovasc Pharmacol Ther; 2011 Mar; 16(1):72-8. PubMed ID: 20938040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic pretreatment with celecoxib reduces infarct size.
    Lada-Moldovan L; Kaloustian S; Bah TM; Girard SA; Déry MA; Rousseau G
    J Cardiovasc Pharmacol; 2009 Jul; 54(1):31-7. PubMed ID: 19528817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cardioprotection of the late phase of ischemic preconditioning is enhanced by postconditioning via a COX-2-mediated mechanism in conscious rats.
    Sato H; Bolli R; Rokosh GD; Bi Q; Dai S; Shirk G; Tang XL
    Am J Physiol Heart Circ Physiol; 2007 Oct; 293(4):H2557-64. PubMed ID: 17704286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant human erythropoietin pretreatment attenuates heart ischemia-reperfusion injury in rats by suppressing the systemic inflammatory response.
    Shen Y; Wang Y; Li D; Wang C; Xu B; Dong G; Huang H; Jing H
    Transplant Proc; 2010 Jun; 42(5):1595-7. PubMed ID: 20620481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Late protective effect of pharmacological preconditioning with total flavones of rhododendra against myocardial ischemia-reperfusion injury.
    Zhang JH; Chen ZW; Wu Z
    Can J Physiol Pharmacol; 2008 Mar; 86(3):131-8. PubMed ID: 18418440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardioprotection during the final stage of the late phase of ischemic preconditioning is mediated by neuronal NO synthase in concert with cyclooxygenase-2.
    Wang Y; Kodani E; Wang J; Zhang SX; Takano H; Tang XL; Bolli R
    Circ Res; 2004 Jul; 95(1):84-91. PubMed ID: 15166094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Erythropoietin protects from reperfusion-induced myocardial injury by enhancing coronary endothelial nitric oxide production.
    Mihov D; Bogdanov N; Grenacher B; Gassmann M; Zünd G; Bogdanova A; Tavakoli R
    Eur J Cardiothorac Surg; 2009 May; 35(5):839-46; discussion 846. PubMed ID: 19237290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous glutamine enhances COX-2 activity giving cardioprotection.
    McGuinness J; Neilan TG; Cummins R; Sharkasi A; Bouchier-Hayes D; Redmond JM
    J Surg Res; 2009 Mar; 152(1):140-7. PubMed ID: 18708191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Constitutive COX-2 activity in cardiomyocytes confers permanent cardioprotection Constitutive COX-2 expression and cardioprotection.
    Inserte J; Molla B; Aguilar R; Través PG; Barba I; Martín-Sanz P; Boscá L; Casado M; Garcia-Dorado D
    J Mol Cell Cardiol; 2009 Feb; 46(2):160-8. PubMed ID: 19084534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.